172 related articles for article (PubMed ID: 36798918)
21. The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population.
Rabiee B; Roozafzai F; Hemasi GR; Poustchi H; Keyvani H; Khonsari MR; Ajdarkosh H; Maadi M; Sima Saeedian F; Zamani F
Middle East J Dig Dis; 2017 Apr; 9(2):86-93. PubMed ID: 28638584
[TBL] [Abstract][Full Text] [Related]
22. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of non-alcoholic fatty liver disease in patients with nephrotic syndrome: A population-based study.
Onwuzo SS; Hitawala AA; Boustany A; Kumar P; Almomani A; Onwuzo C; Monteiro JM; Asaad I
World J Hepatol; 2023 Feb; 15(2):265-273. PubMed ID: 36926242
[TBL] [Abstract][Full Text] [Related]
24. Nonalcoholic Fatty Liver Disease Is Not Associated with Thyroid Hormone Levels and Hypothyroidism: A Systematic Review and Meta-Analysis.
Jaruvongvanich V; Sanguankeo A; Upala S
Eur Thyroid J; 2017 Jul; 6(4):208-215. PubMed ID: 28868261
[TBL] [Abstract][Full Text] [Related]
25. Non-alcoholic fatty liver disease across the spectrum of hypothyroidism.
Chung GE; Kim D; Kim W; Yim JY; Park MJ; Kim YJ; Yoon JH; Lee HS
J Hepatol; 2012 Jul; 57(1):150-6. PubMed ID: 22425701
[TBL] [Abstract][Full Text] [Related]
26. Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients.
Liu L; Yu Y; Zhao M; Zheng D; Zhang X; Guan Q; Xu C; Gao L; Zhao J; Zhang H
Int J Endocrinol; 2017; 2017():5753039. PubMed ID: 28473851
[No Abstract] [Full Text] [Related]
27. Nonalcoholic fatty liver disease in a cluster of Iranian population: thyroid status and metabolic risk factors.
Eshraghian A; Dabbaghmanesh MH; Eshraghian H; Fattahi MR; Omrani GR
Arch Iran Med; 2013 Oct; 16(10):584-9. PubMed ID: 24093139
[TBL] [Abstract][Full Text] [Related]
28. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
[TBL] [Abstract][Full Text] [Related]
29. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
30. Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study.
Targher G; Mantovani A; Grander C; Foco L; Motta B; Byrne CD; Pramstaller PP; Tilg H
Nutr Metab Cardiovasc Dis; 2021 Nov; 31(12):3464-3473. PubMed ID: 34627696
[TBL] [Abstract][Full Text] [Related]
31. Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes.
Mantovani A; Rigolon R; Mingolla L; Pichiri I; Cavalieri V; Salvotelli L; Stoico V; Zoppini G; Bonora E; Targher G
J Diabetes Complications; 2017 Jun; 31(6):1021-1026. PubMed ID: 28254449
[TBL] [Abstract][Full Text] [Related]
32. Circulating fatty acid-binding protein 1 (FABP1) and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Lu YC; Chang CC; Wang CP; Hung WC; Tsai IT; Tang WH; Wu CC; Wei CT; Chung FM; Lee YJ; Hsu CC
Int J Med Sci; 2020; 17(2):182-190. PubMed ID: 32038102
[No Abstract] [Full Text] [Related]
33. Correlation between subclinical hypothyroidism and renal function in patients with diabetes mellitus.
Zhang L; Yang G; Su Z; Yang J
Nephrology (Carlton); 2017 Oct; 22(10):790-795. PubMed ID: 27412074
[TBL] [Abstract][Full Text] [Related]
34. Subclinical hypothyroidism as a risk factor for the development of cardiovascular disease in obese adolescents with nonalcoholic fatty liver disease.
Sert A; Pirgon O; Aypar E; Yilmaz H; Odabas D
Pediatr Cardiol; 2013 Jun; 34(5):1166-74. PubMed ID: 23344895
[TBL] [Abstract][Full Text] [Related]
35. Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Mantovani A; Nascimbeni F; Lonardo A; Zoppini G; Bonora E; Mantzoros CS; Targher G
Thyroid; 2018 Oct; 28(10):1270-1284. PubMed ID: 30084737
[TBL] [Abstract][Full Text] [Related]
36. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH.
Ampuero J; Aller R; Gallego-Durán R; Crespo J; Calleja JL; García-Monzón C; Gómez-Camarero J; Caballería J; Lo Iacono O; Ibañez L; García-Samaniego J; Albillos A; Francés R; Fernández-Rodríguez C; Diago M; Soriano G; Andrade RJ; Latorre R; Jorquera F; Morillas RM; Escudero D; Estévez P; Guerra MH; Augustín S; Banales JM; Aspichueta P; Benlloch S; Rosales JM; Salmerón J; Turnes J; Romero Gómez M;
J Hepatol; 2020 Jul; 73(1):17-25. PubMed ID: 32147361
[TBL] [Abstract][Full Text] [Related]
37. Low serum CTRP3 levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Zhang J; Zhang B; Cheng Y; Xu J
Cytokine; 2018 Jun; 106():131-135. PubMed ID: 29113741
[TBL] [Abstract][Full Text] [Related]
38. The associations of total testosterone with probable nonalcoholic steatohepatitis and nonalcoholic fatty liver disease fibrotic progression in men with type 2 diabetes: a cross-sectional study.
Zhang Z; Chen C; Wang Y; Wang N; Chen Y; Lu Y; Xia F
Eur J Med Res; 2022 Dec; 27(1):307. PubMed ID: 36572925
[TBL] [Abstract][Full Text] [Related]
39. Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes.
Yamazaki H; Tsuboya T; Tsuji K; Dohke M; Maguchi H
Diabetes Care; 2015 Sep; 38(9):1673-9. PubMed ID: 26156527
[TBL] [Abstract][Full Text] [Related]
40. Correlation between the thyroid hormone levels and nonalcoholic fatty liver disease in type 2 diabetic patients with normal thyroid function.
Zhang Y; Li J; Liu H
BMC Endocr Disord; 2022 May; 22(1):144. PubMed ID: 35641932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
